Arsip Agonist

SCREENING FOR PPAR Γ AGONIST FROM MYRISTICA FRAGRANS HOUTT SEEDS FOR THE TREATMENT OF TYPE 2 DIABETES BY IN VITRO AND IN VIVO

In general, a type two diabetes mellitus (T2DM) patient suffers ...

IN SILICO EVALUATION OF POTENT FOR PPARΓ AGONIST OF LIGNAN DERIVATIVES FROM MYRISTICA FRAGRANS HOUTT SEEDS

Objective: Peroxisome proliferator-activated receptors gamma (PPARy) is a clinically established ...